Showing 81 - 100 results of 65,676 for search '(((( 50 ms decrease ) OR ( 50 ((ms decrease) OR (mean decrease)) ))) OR ( 5 a decrease ))', query time: 0.95s Refine Results
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91

    Characteristics of Gasless Combustion of Core–Shell Al@NiO Microparticles with Boosted Exothermic Performance by Shina Maini (19413980)

    Published 2024
    “…The PM composite was not able to be ignited at all by a 5 W laser, while the core–shell counterpart ignited at 2.55 ms and was completely combusted within 6.50 ms accompanying a violent impulse.…”
  12. 92

    Characteristics of Gasless Combustion of Core–Shell Al@NiO Microparticles with Boosted Exothermic Performance by Shina Maini (19413980)

    Published 2024
    “…The PM composite was not able to be ignited at all by a 5 W laser, while the core–shell counterpart ignited at 2.55 ms and was completely combusted within 6.50 ms accompanying a violent impulse.…”
  13. 93

    Description of the myofascial release techniques. by Sergio R. Thomaz (20308465)

    Published 2024
    “…</b></p><p>Results</p><p>Thirty-eight patients (14 in CRT, 14 in CRT+MRT, and 10 in RUHB), with a mean age of 55 years and 50% male, completed the study. …”
  14. 94

    Study flow diagram. by Sergio R. Thomaz (20308465)

    Published 2024
    “…</b></p><p>Results</p><p>Thirty-eight patients (14 in CRT, 14 in CRT+MRT, and 10 in RUHB), with a mean age of 55 years and 50% male, completed the study. …”
  15. 95

    Clinical characteristics of the study population. by Sergio R. Thomaz (20308465)

    Published 2024
    “…</b></p><p>Results</p><p>Thirty-eight patients (14 in CRT, 14 in CRT+MRT, and 10 in RUHB), with a mean age of 55 years and 50% male, completed the study. …”
  16. 96
  17. 97
  18. 98
  19. 99

    Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC–MS/MS-Based Glycoproteomic Approach by Jingfu Zhao (3113421)

    Published 2020
    “…Here, we applied an LC–MS/MS-based glycoproteomics approach to characterize Fc glycans of an NISTmAb reference material (RM) 8671 (sample B) and a β-1,4-galactosidase-treated NISTmAb (sample A). …”
  20. 100